載入...
CELLULAR AND MOLECULAR IMMUNOLOGY OF LUNG CANCER: THERAPEUTIC IMPLICATIONS
Though incidence is declining, the prognosis of lung cancer remains poor. This is likely due to lack of early detection and only recent developments in selective cancer therapies. Key immune cells involved in the pathogenesis of lung cancer include CD4(+) T-lymphocytes, macrophages, dendritic cells,...
Na minha lista:
| 發表在: | Expert Rev Clin Immunol |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4596236/ https://ncbi.nlm.nih.gov/pubmed/25351434 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/1744666X.2014.975692 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|